Cargando…

Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes

Background: The impact of COVID-19 on respiratory outcomes in people with cystic fibrosis (pwCF) has not been clearly characterized. We evaluated changes in respiratory function indicators derived from spirometry and pulmonary exacerbation rates 6 months after SARS-CoV-2 infection. Methods: This mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medino, Paola, Alicandro, Gianfranco, Rosazza, Chiara, Ciciriello, Fabiana, Gramegna, Andrea, Biffi, Arianna, Daccò, Valeria, Lucidi, Vincenzina, Cipolli, Marco, Boraso, Mariaserena, Nazzari, Erica, Colombo, Carla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687883/ https://www.ncbi.nlm.nih.gov/pubmed/36359291 http://dx.doi.org/10.3390/biomedicines10112771

Ejemplares similares

P054 Severity of COVID-19 infection in cystic fibrosis patients compared to the general population
por: Rosazza, C., et al.
Publicado: (2022)

534 COVID-19 in people with cystic fibrosis and the general population: Severity and virus-host cell interactions
por: Colombo, C., et al.
Publicado: (2022)

Severity of SARS-CoV-2 infection in a hospital population: a clinical comparison across age groups
por: Rosazza, Chiara, et al.
Publicado: (2023)

Immunogenicity of BNT162b2 mRNA-Based Vaccine against SARS-CoV-2 in People with Cystic Fibrosis According to Disease Characteristics and Maintenance Therapies
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

Prepuberal insulin secretory indices are long-term predictors of short adult stature in cystic fibrosis
por: Battezzati, Alberto, et al.
Publicado: (2022)

P212 Clinical and transcriptomic features of COVID-19 in cystic fibrosis: a prospective multi-centre study
por: Ciciriello, F., et al.
Publicado: (2023)

SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society
por: Colombo, Carla, et al.
Publicado: (2021)

Breastfeeding in Cystic Fibrosis: A Systematic Review on Prevalence and Potential Benefits
por: Colombo, Carla, et al.
Publicado: (2021)

Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Alicandro, G., et al.
Publicado: (2023)

Distribution of OGTT-Related Variables in Patients with Cystic Fibrosis from Puberty to Adulthood: An Italian Multicenter Study
por: Foppiani, Andrea, et al.
Publicado: (2023)

532 Humoral and cell-mediated responses to BNT162b2 mRNA vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Daccò, V., et al.
Publicado: (2022)

ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Alicandro, G., et al.
Publicado: (2022)

A successful treatment of a lobar atelectasis in a patient with cystic fibrosis
por: Daccò, Valeria, et al.
Publicado: (2022)

SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020
por: Colombo, Carla, et al.
Publicado: (2021)

An inflammatory Signature of Glucose Impairment in Cystic Fibrosis
por: Montemari, Anna Lisa, et al.
Publicado: (2022)

Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells
por: Scudieri, Paolo, et al.
Publicado: (2020)

Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion
por: Colombo, C., et al.
Publicado: (2021)

Profiling the response to lumacaftor‐ivacaftor in children with cystic between fibrosis and new insight from a French‐Italian real‐life cohort
por: Cornet, Matthieu, et al.
Publicado: (2022)

Liposomes Loaded With Phosphatidylinositol 5-Phosphate Improve the Antimicrobial Response to Pseudomonas aeruginosa in Impaired Macrophages From Cystic Fibrosis Patients and Limit Airway Inflammatory Response
por: Poerio, Noemi, et al.
Publicado: (2020)

Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes
por: Grancini, V., et al.
Publicado: (2023)

P134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multi-centre prospective study with a control group
por: Colombo, C., et al.
Publicado: (2021)

ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)
por: Lucca, F., et al.
Publicado: (2022)

Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2023)

A case of testicular atrophy associated with cystic fibrosis
por: Profka, Eriselda, et al.
Publicado: (2020)

Clinical expression of cystic fibrosis in a large cohort of Italian siblings
por: Terlizzi, Vito, et al.
Publicado: (2018)

Night Blindness in Cystic Fibrosis: The Key Role of Vitamin A in the Digestive System
por: Norsa, Lorenzo, et al.
Publicado: (2019)

A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics
por: Vernocchi, Pamela, et al.
Publicado: (2017)

Is cellular senescence involved in cystic fibrosis?
por: Bezzerri, Valentino, et al.
Publicado: (2019)

Does cystic fibrosis constitute an advantage in COVID-19 infection?
por: Bezzerri, Valentino, et al.
Publicado: (2020)

Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study
por: Dolce, Daniela, et al.
Publicado: (2019)

Bone and body composition analyzed by Dual-energy X-ray Absorptiometry (DXA) in clinical and nutritional evaluation of young patients with Cystic Fibrosis: a cross-sectional study
por: Lucidi, Vincenzina, et al.
Publicado: (2009)

Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy
por: D'Apice, Maria Rosaria, et al.
Publicado: (2004)

Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis
por: Sofia, Valentina Maria, et al.
Publicado: (2018)

State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis” (MAESTRO) consortium
por: Ciet, Pierluigi, et al.
Publicado: (2022)

Somatostatin Modulates Insulin-Degrading-Enzyme Metabolism: Implications for the Regulation of Microglia Activity in AD
por: Tundo, Grazia, et al.
Publicado: (2012)

A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease
por: Bacci, Giovanni, et al.
Publicado: (2017)

Untargeted Metagenomic Investigation of the Airway Microbiome of Cystic Fibrosis Patients with Moderate-Severe Lung Disease
por: Bacci, Giovanni, et al.
Publicado: (2020)

Changes in Cystic Fibrosis Airway Microbial Community Associated with a Severe Decline in Lung Function
por: Paganin, Patrizia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vobhk6e5m6vv84deos36s7g5oj